Lipid mediator profile in vernix caseosa reflects skin barrier development

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Checa, Antonio ^a   Holm, Tina ^a   Sjodin, Marcus O D ^a   Reinke, Stacey N ^a   Alm, Johan ^a   Scheynius, Annika ^a   Wheelock, Craig E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID; GLYCERYL 2-ARACHIDONATE; ICOSANOID; LIPID; SPHINGOMYELIN;

ADULT; CHILD; FEMALE; GESTATIONAL AGE; HUMAN; MALE; METABOLISM; NEWBORN; PHYSIOLOGY; SKIN; VERNIX CASEOSA;

ADULT; ARACHIDONIC ACIDS; CHILD; EICOSANOIDS; ENDOCANNABINOIDS; FEMALE; GESTATIONAL AGE; GLYCERIDES; HUMANS; INFANT, NEWBORN; LIPIDS; MALE; SKIN; SPHINGOMYELINS; VERNIX CASEOSA;

EID: 84946064547     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15740     Document Type: Article

References (28)

1. Hoeger, P. H. et al. Epidermal barrier lipids in human vernix caseosa: corresponding ceramide pattern in vernix and fetal skin. Br J Dermatol 146, 194-201 (2002).
2. Tollin, M. et al. Vernix caseosa as a multi-component defence system based on polypeptides, lipids and their interactions. Cell Mol Life Sci 62, 2390-2399 (2005).
3. Visscher, M. O. et al. Vernix caseosa in neonatal adaptation. J Perinatol 25, 440-446 (2005).
4. Kendall, A. C., Nicolaou, A. Bioactive lipid mediators in skin inflammation and immunity. Prog Lipid Res 52, 141-164 (2013).
5. Nicolaou, A. Eicosanoids in skin inflammation. Prostaglandins Leukot Essent Fatty Acids 88, 131-138 (2013).
6. Mikova, R. et al. Newborn boys and girls differ in the lipid composition of vernix caseosa. PLoS ONE 9, e99173 (2014).
7. Stenius, F. et al. Lifestyle factors and sensitization in children-the ALADDIN birth cohort. Allergy 66, 1330-1338 (2011).
8. Visscher, M. O., Adam, R., Brink, S., Odio, M. Newborn infant skin: physiology, development, and care. Clin Dermatol 33, 271-280 (2015).
9. Raone, B., Raboni, R., Rizzo, N., Simonazzi, G., Patrizi, A. Transepidermal water loss in newborns within the first 24 hours of life: baseline values and comparison with adults. Pediatr Dermatol 31, 191-195 (2014).
10. Meckfessel, M. H., Brandt, S. The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products. J Am Acad Dermatol 71, 177-184 (2014).
11. Rissmann, R. et al. New insights into ultrastructure, lipid composition and organization of vernix caseosa. J Invest Dermatol 126, 1823-1833 (2006).
12. Hamanaka, S. et al. Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 119, 416-423 (2002).
13. Breiden, B., Sandhoff, K. The role of sphingolipid metabolism in cutaneous permeability barrier formation. Biochim Biophys Acta 1841, 441-452 (2014).
14. Hanley, K. et al. Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat. Acceleration by estrogen and delay by testosterone. J Clin Invest 97, 2576-2584 (1996).
15. Nazzaro-Porro, M., Passi, S., Boniforti, L., Belsito, F. Effects of aging on fatty acids in skin surface lipids. J Invest Dermatol 73, 112-117 (1979).
16. Pucci, M., Pirazzi, V., Pasquariello, N., Maccarrone, M. Endocannabinoid signaling and epidermal differentiation. Eur J Dermatol 21 Suppl 2, 29-34 (2011).
17. Taylor, A. H. et al. Endocannabinoids and pregnancy. Clin Chim Acta 411, 921-930 (2010).
18. Rapino, C., Battista, N., Bari, M., Maccarrone, M. Endocannabinoids as biomarkers of human reproduction. Hum Reprod Update 20, 501-516 (2014).
19. Maccarrone, M. et al. The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem 278, 33896-33903 (2003).
20. Sánchez, C. et al. The CB1 Cannabinoid Receptor of Astrocytes Is Coupled to Sphingomyelin Hydrolysis through the Adaptor Protein Fan. Molecular Pharmacology 59, 955-959 (2001).
21. Schmelzer, K. R. et al. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci USA 102, 9772-9777 (2005).
22. Ansari, M. N. A., Nicolaides, N., Fu, H. C. Fatty acid composition of the living layer and stratum corneum lipids of human sole skin epidermis. Lipids 5, 838-845 (1970).
23. Fava, C., Ricci, M., Melander, O., Minuz, P. Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: A sex-specific relation? Prostaglandins & Other Lipid Mediators 98, 75-85 (2012).
24. Shaner, R. L. et al. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J Lipid Res 50, 1692-1707 (2009).
25. Checa, A. et al. Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis. Multiple Sclerosis Journal 21, 1271-1279 (2015).
26. Lundstrom, S. L. et al. Asthmatics exhibit altered oxylipin profiles compared to healthy individuals after subway air exposure. PLoS ONE 6, e23864 (2011).
27. Huber, P. J. The behavior of maximum likelihood estimates under nonstandard conditions. In Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, Volume 1: Statistics 221-233 (University of California Press, Berkeley, Calif., 1967).
28. Storey, J. D., Tibshirani, R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100, 9440-9445 (2003).